Drug Type TCR therapy |
Synonyms- |
Target |
Mechanism LMP2 modulators(Latent membrane protein 2 modulators), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and neck cancer metastatic | Phase 1 | CN | 07 Aug 2019 | |
Nasopharyngeal Cancer, Recurrent | Phase 1 | CN | 07 Aug 2019 |